Related Experiment Video
Updated: Jun 23, 2026

Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice
Published on: April 26, 2024
Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE
Ruth D E Fritsch-Stork1, Roos J Leguit, Ronald H W M Derksen
1Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, The Netherlands. r.fritsch@umcutrecht.nl
Background:
A 57-year-old Afro-Jamaican woman with an 8-year history of systemic lupus erythematosus, including lupus nephritis, was admitted to hospital with intractable back pain accompanied by fever and severe malaise. At the time of presentation she was receiving immunosuppressive treatment with glucocorticoids and azathioprine. She also had gout, hypertension and type II diabetes.
Investigations:
Physical and neurological examination and laboratory analyses, including biochemical, hematological and electrophoresis tests, X-ray of the lumbar spine, pelvis and chest, mammography, MRI of the lumbar spine, thoracic and abdominal CT, and biopsy of a peripheral lymph node and bone marrow with immunohistochemistry and serology for human T-cell lymphotrophic virus (HTLV) 1 and 2.
Diagnosis:
HTLV-1-associated acute adult T-cell leukemia/lymphoma with bone marrow infiltration and hypercalcemia. Reaching the correct diagnosis was difficult and only possible through close collaboration with the pathologist and with consideration of the patient's ethnic and geographical background.
Management:
Chemotherapy with high-dose prednisone and adjusted doses of cyclophosphamide and doxorubicin. The patient developed tumor lysis syndrome and died 3 weeks after the diagnosis was made.
Related Concept Videos
Cytomegalovirus Disease
Huntington Disease l: Introduction
Graves' Disease I: Introduction
Mechanisms of Retrovirus-induced Cancers
Rabies
Cryptococcal Meningitis
